We hypothesize that the herbal compound SHYZD can effectively treat AD by inhibiting the neuroinflammation-related NF-κB/NLRP3 signalling pathway and regulating downstream inflammatory factors. The gene discussed is NLRP3; the disease is Alzheimer disease.